Korro Bio, Inc. Net Income Loss

• Korro Bio, Inc. showed a decrease of -40.3% in Net Income Loss from 2024 to 2025.
• This data is from Korro Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 9 years of available data (2017 to 2025), Korro Bio, Inc.'s Net Income Loss has declined by 479.4%.
• Historical annual values: Fiscal year 2025: -$117.26 million | Fiscal year 2024: -$83.58 million | Fiscal year 2023: -$81.17 million | Fiscal year 2022: -$58.03 million | Fiscal year 2021: -$84.69 million | Fiscal year 2020: -$26.51 million | Fiscal year 2019: -$18.75 million | Fiscal year 2018: -$19.17 million | Fiscal year 2017: -$20.24 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026